CHICAGO, Oct 17 (Reuters) - JP Morgan said on Tuesday that U.S. regulators have canceled an orthopedic device panel meeting tentatively set for December, posing a potential delay for Stryker Corp.'s (SYK.N: Quote, Profile, Research) OP-1 biologic putty.
